SENISCA Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
SENISCA is a biotechnology research spinout from the University of Exeter, founded in 2020 and headquartered in Exeter, England. It develops approaches to reverse cellular senescence, pursuing senotherapeutics aimed at restoring cells' ability to fine-tune gene expression to rejuvenate aged cells. The focus includes oligonucleotide-based interventions intended to turn back aging processes and address age-related diseases and signs. The company serves research-focused biotech and pharmaceutical developers seeking new therapies for aging and related conditions, drawing on insights into why cells become senescent. Positioned within the biotechnology research sector, it concentrates on RNA-based therapeutics targeting cellular aging. A notable leadership development in 2024 was the appointment of Tim Edwards as Chair of the Board.